Sectors
SABS
SAB Biotherapeutics, Inc.
3.85
1 x 3.30
1 x 4.29
bid
ask
+
0.08
2.12%
1 @ 04:00 PM
3.76 -0.09 (2.34%)
| Ytd | 2.94% | |
| 1y | 75.80% |
3.61
day range
3.87
1.85
52 week range
5.15
| Open | 3.76 | Prev Close | 3.77 | Low | 3.61 | High | 3.87 | Mkt Cap | 36.80M |
| Vol | 274.49K | Avg Vol | 898.56K | EPS | -1.30 | P/E | -2.96 | Forward P/E | -1.56 |
| Beta | 0.53 | Short Ratio | 1.22 | Inst. Own | 34.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.66 | 200-d Avg | 3.75 | 1yr Est | 12.40 |
SABS News
globenewswire.com
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
Over 60 clinical sites activated in registrational SAFEGUARD study of SAB-142 in Stage 3 new onset t
benzinga.com
SAB Biotherapeutics Receives Breakthrough T1D Grant To Advance SAB-142 Study In Newly Diagnosed Type
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SA
benzinga.com
Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst r
benzinga.com
Earnings Scheduled For May 12, 2026